Providing a launch pad for the next generation of research discovery
Kristof Wing always knew that he wanted to make a difference to people’s lives. With the help of a Cancer Council scholarship, he was able to embark on a career involving research having both positive impacts on preclinical research here and overseas.
When Kristof was offered the once in a lifetime opportunity to conduct his honours research at a world leading laboratory in Germany, he needed financial support for it to be a success. So he applied for the Evelyn Pederson Honours Scholarship.
Funded by a generous bequest by Tasmanian Evelyn Pedersen, this scholarship is awarded annually by Cancer Council and the University of Tasmania to the best and brightest undergraduate students wishing to undertake research into any area of cancer. The scholarship is designed to provide much needed support for the living and research expenses associated with a university honours year. It is one of many scholarships provided by Cancer Council to students who are keen to make a difference to the lives of people impacted by cancer. These scholarships vary in focus and size, but they are all designed to support our next generation of researchers and health professionals.
The support I received from Cancer Council has meant everything for my career. The Evelyn Pederson Honours Scholarship meant I was able to put all of my energy into research for that year as well as building valuable skills and relationships for the future.
With his expenses taken care of, Kristof was free to dedicate all of his time towards his research project and that dedication has paid off in spades.
Working with Professor Dirk Busch at the Technical University of Munich, Kristof focused his energy on improving how certain types of cancer immunotherapies are developed, personalised and delivered to patients. While his thesis was technical in nature, his results have already had positive impacts on preclinical research both here and overseas. Importantly, he has brought the techniques he championed in Germany back to Australia where they are now in regular use.
As our technology becomes more refined and we are more able to produce a higher-quality cell product, we can potentially produce a wider range of therapies for different cancer types that are currently resistant to treatments.
Today, Kristof is in his final year of medicine but still fitting in some research work around his busy study schedule. He’s looking forward to combining the research skills he has learnt with his medical practice to improve and advance our understanding of human health and is extraordinarily grateful for the opportunity given to him by Cancer Council.
More stories for you:
Looking AheadWith your help, we'll continue funding the brightest minds all over Australia to push even more boundaries and break new ground.